Cell line · CVCL_1622
OE19
Cancer cell line, Homo sapiens. Esophageal adenocarcinoma. 42 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. OE19. Cell lines, record CVCL_1622. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1622
On this page
Cell line
As Cellosaurus gives it.
- Name
- OE19
- Accession
- CVCL_1622
- RRID
- RRID:CVCL_1622
- Synonyms
- OE-19, JROECL 19, JROECL19, OEC19
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 72Y
- Category
- Cancer cell line
- Diseases
- Esophageal adenocarcinoma (NCIt C4025); Adenocarcinoma of the esophagus (ORDO Orphanet_99976)
- Derived from
- Esophagus (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers42
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| A First-in-Class LZK Inhibitor Suppresses Tumor Growth and Potentiates EGFR and PI3K Pathway Blockade in Head and Neck and Esophageal Cancers. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Alcohol exposure promotes cell communication network 1 cleavage in esophageal adenocarcinoma cells exclusively. | J Cell Commun Signal | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Suppression of AKT Activation through LZK Inhibition Limits Tumor Growth in Esophageal and Head and Neck Cancers. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Early-stage multi-cancer detection through a plasma extracellular vesicle protein signature. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Multi-omic integration identifies broad drug resistance mechanisms and strategies to therapeutically reprogram cancer cells. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Pertuzumab Enhances the Antitumor Activity of T-DXd in HER2-Positive Gastric Cancer Cells. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MicroRNA 196a contributes to the aggressiveness of esophageal adenocarcinoma through the MYC/TERT/NFκB axis. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine release. | J Immunother Cancer | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Primate retroelement exonization and sexually dimorphic IL13RA1 transcription tune type 2 immune responses. | Sci Immunol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Retroelement co-option disrupts the cancer transcriptional programme. | Genome Med | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 42
See all 42 papersRelatives0
None in this release.
Cell banks2
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1622
GET https://conductscience.org/api/cell-lines/v1/CVCL_1622/papers?page=2